Reply Letter – to Urso et al “Comment on: Comparative dissolution profiles of two anti-emetic delayed release dosage forms of doxylamine and pyridoxine: Xonvea® tablets vs. Cariban® capsules”
C. Alcocer, E. Rom, P.-A. Regidor Laboratorios Liconsa, Azuqueca de Henares, Spain. Pedro-antonio.regidor@exeltis.com
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
C. Alcocer, E. Rom, P.-A. Regidor
Reply Letter – to Urso et al “Comment on: Comparative dissolution profiles of two anti-emetic delayed release dosage forms of doxylamine and pyridoxine: Xonvea® tablets vs. Cariban® capsules”
Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 23
Pages: 8635-8636
DOI: 10.26355/eurrev_202212_30533